Probe Capital

Founded in 2017 and based in Beijing, China, Probe Capital is a a medical service company that focuses on healthcare and life sciences. It has established departments in Beijing, Shanghai, Zhejiang, Jiangsu, Sichuan and other places. In May 2025, Probe Capital closed a venture funding round from new investor Nanhui Capital. The company has developed the industry data platform Shennong No.

1 based on technologies such as big data and artificial intelligence. Shennong No. 1 provides financing and mergers and acquisitions, industry consulting, corporate financial advisory, industry investment and operation, equity investment and other services to medical innovation companies, governments and industrial departments. The company has built a medical health and life science industry tracking system that can track regulatory policies, scientific research topics, patents, registration certificates, investment and financing trends and other information.

Probe Capital generates revenue by providing medical health and life science data service platform, Shenzhen Agricultural No. 1. The company will use the venture funding in May 2025 for investment and incubation in hard technology industries, accelerate the intelligent upgrade of the Shennong No. 1 industrial data platform, and build an industrial service system for governments and enterprises.